Company-wide revenue
Reported revenue in 2020 ¥22.37B Reported revenue in 2024 ¥32.66B
- growth amount
- +¥10.29B
- growth annualized
- +9.9%
- growth total
- +46.0%
Japanese company profile · 2927
AFC-HD AMS Life Science Co.,Ltd.
In its FY2024 public filing, AFC-HD AMS Life Science Co.,Ltd. reports Healthcare, Pharmaceuticals, Department Store Business, Food Service, and 1 other reported businesses. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社ＡＦＣ－ＨＤアムスライフサイエンス
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
AFC-HD AMS Life Science Co.,Ltd.'s largest reported business by revenue in FY2024 was Healthcare.
The business with the highest reported segment profit in FY2024 was Healthcare.
FY2024 · fiscal year ended August 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Healthcare | ¥19.04B ↗ | 58.3% | ¥2.45B ↗ |
| Department Store Business | ¥4.62B ↗ | 14.2% | ¥61.8M ↗ |
| Real estate and construction | ¥2.71B ↗ | 8.3% | ¥16.57M ↗ |
| Pharmaceuticals | ¥2.48B ↗ | 7.6% | ¥230.77M ↗ |
| Food Service | ¥2.41B ↗ | 7.4% | −¥74.87M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2024 · fiscal year ended August 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Healthcare
- ヘルスケア事業
- Pharmaceuticals
- 医薬品事業
- Department Store Business
- 百貨店事業
- Food Service
- 飲食事業
- Real estate and construction
- 不動産・建託事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Healthcare
- ヘルスケア事業
- Pharmaceuticals
- 医薬品事業
- Department Store Business
- 百貨店事業
- Food Service
- 飲食事業
- Real estate and construction
- 不動産・建託事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Healthcare | ¥17.43B | ¥15.14B | ¥15.25B | ¥18.2B | ¥19.04B |
| Pharmaceuticals | ¥1.57B | ¥1.78B | ¥2.09B | ¥2.31B | ¥2.48B |
| Department Store Business | ¥3.21B | ¥4.7B | ¥5.2B | ¥4.95B | ¥4.62B |
| Food Service | ¥157.55M | ¥920.51M | ¥1.48B | ¥2.18B | ¥2.41B |
| Real estate and construction | — | — | — | ¥1.95B | ¥2.71B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Food Service
Reported revenue in 2020 ¥157.55M Reported revenue in 2024 ¥2.41B
- growth amount
- +¥2.25B
- growth annualized
- +97.7%
- growth total
- +1,428.6%
View original filing
Healthcare
Reported revenue in 2021 ¥15.14B Reported revenue in 2024 ¥19.04B
- growth amount
- +¥3.9B
- growth annualized
- +7.9%
- growth total
- +25.8%
View original filing
Pharmaceuticals
Reported revenue in 2020 ¥1.57B Reported revenue in 2024 ¥2.48B
- growth amount
- +¥910.23M
- growth annualized
- +12.1%
- growth total
- +57.9%
View original filing
Food Service
Reported profit margin in 2021 -38.5%
Reported profit margin in 2024 -3.1%
- growth margin points
- +35.4
View original filing
Department Store Business
Reported profit margin in 2021 -5.3%
Reported profit margin in 2024 +1.3%
- growth margin points
- +6.6
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2024 · fiscal year ended August 2025
The source document may be in Japanese.
Filing ID: S100X6W8
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.